Enzo Biochem, Inc. ($0.01 Par Value) (ENZ): Price and Financial Metrics


Enzo Biochem, Inc. ($0.01 Par Value) (ENZ)

Today's Latest Price: $2.37 USD

0.05 (2.16%)

Updated Sep 17 6:40pm

Add ENZ to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

ENZ Stock Summary

  • With a one year PEG ratio of 0.12, Enzo Biochem Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 3.17% of US stocks.
  • Enzo Biochem Inc's stock had its IPO on January 1, 1986, making it an older stock than 92.83% of US equities in our set.
  • Over the past twelve months, ENZ has reported earnings growth of -3,034.89%, putting it ahead of merely 0.5% of US stocks in our set.
  • Stocks that are quantitatively similar to ENZ, based on their financial statements, market capitalization, and price volatility, are JMP, MYGN, OFIX, NTWK, and ICLK.
  • Visit ENZ's SEC page to see the company's official filings. To visit the company's web site, go to www.enzo.com.
ENZ Daily Price Range
ENZ 52-Week Price Range

ENZ Stock Price Chart Technical Analysis Charts


ENZ Price/Volume Stats

Current price $2.37 52-week high $4.85
Prev. close $2.32 52-week low $1.56
Day low $2.30 Volume 166,500
Day high $2.40 Avg. volume 825,215
50-day MA $2.40 Dividend yield N/A
200-day MA $2.50 Market Cap 113.50M

Enzo Biochem, Inc. ($0.01 Par Value) (ENZ) Company Bio


Enzo Biochem, Inc. engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company was founded in 1976 and is based in New York, New York.


ENZ Latest News Stream


Event/Time News Detail
Loading, please wait...

ENZ Latest Social Stream


Loading social stream, please wait...

View Full ENZ Social Stream

Latest ENZ News From Around the Web

Below are the latest news stories about Enzo Biochem Inc that investors may wish to consider to help them evaluate ENZ as an investment opportunity.

If You Had Bought Enzo Biochem's (NYSE:ENZ) Shares Three Years Ago You Would Be Down 78%

Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...

Yahoo | September 15, 2020

ENZO BIOCHEM DOUBLES CAPACITY IN RESPONSE TO INCREASING DEMAND FOR COVID-19 TESTING

Facility in Farmingdale, NY, expanding manufacturing and molecular platform to support rapidly growing demand for testing services from universities, nursing homes, physician offices and urgent care facilities.NEW YORK, NY, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it has expanded reagent and supply manufacturing as well as doubled its capacity for molecular laboratory testing services at its facilities in Farmingdale, NY to meet rapidly increasing demand for its PCR-based COVID-19 molecular and serological testing.   Demand for testing services has expanded significantly throughout the multi-state New York metropolitan region, including support for testing programs at academic institutions, phys...

Yahoo | September 8, 2020

Edited Transcript of ENZ earnings conference call or presentation 8-Jun-20 9:00pm GMT

Q3 2020 Enzo Biochem Inc Earnings Call

Yahoo | August 3, 2020

Enzo Biochem to provide COVID-19 testing at 50+ New York pharmacies

Enzo Biochem ([[ENZ]] -0.6%) partners with Community Pharmacy Enhanced Services Network, to provide COVID-19 testing at 52 of the network’s 155 pharmacies across New York State.The company will provide the full range of services, including reagent manufacturing capabilities, diagnostic instruments, and clinical laboratory services....

Seeking Alpha | July 21, 2020

ENZO BIOCHEM TO PROVIDE ACCESS TO COVID-19 TESTING AT MORE THAN 50 NY PHARMACIES IN COLLABORATION WITH CPESN NY

NEW YORK, NY, July 21, 2020 -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostic company, and Community Pharmacy Enhanced Services Network (CPESN® NY), the.

Yahoo | July 21, 2020

Read More 'ENZ' Stories Here

ENZ Price Returns

1-mo 0.42%
3-mo 5.33%
6-mo -14.75%
1-year -33.61%
3-year -77.32%
5-year -22.04%
YTD -9.89%
2019 -5.40%
2018 -65.89%
2017 17.44%
2016 54.22%
2015 1.35%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.807 seconds.